The Yorkshire Lung Screening Trial: Biomarker study content
Detecting lung cancer through screening saves lives.
The Yorkshire Lung Screening Trial (YLST) will test community-based lung cancer screening in mobile vans across Leeds to work out who would most benefit from screening.
The aim is to maximise this valuable opportunity by taking a blood sample when people attend the mobile vans for their scan to look for signs of lung cancer and address the following important questions:
- Can a blood test more accurately determine who should have a scan?
- Can a blood test be used to detect lung cancer earlier?
- Can a blood test improve the performance of scans?
Lead researcher
Professor Matthew Callister
Consultant Respiratory Physician, University of Leeds
Professor Philip Crosbie
Senior Clinical Lecturer & Consultant in Respiratory Medicine, University of Manchester
Improving radiotherapy for lung cancer
Radiotherapy treatment for lung cancer can sometimes damage the heart. Researchers at Leeds Teaching…
POINTER-PC: Enhancing radiotherapy for prostate cancer
A different way of treating people with prostate cancer is being investigated by researchers at the…
Every 17 minutes someone is diagnosed with cancer in Yorkshire
Our aim is for more people to survive cancer, here in Yorkshire and beyond.
Please help us continue to fund life-saving research.